Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C

Transplantation

Volumn 84, Issue 2, 2007, Pages 144-148

  Bahra, Marcus ^a   Jacob, Dietmar ^a   Neumann, Ulf P ^a   Spies, Fabian ^a   Langrehr, Jan M ^a   Berg, Thomas ^a   Neuhaus, Ruth ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Donor factors; Hepatitis C virus; Liver transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; FAT CONTENT; FAT NECROSIS; FEMALE; FIBROSIS; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFLAMMATION; INTENSIVE CARE; LIVER GRAFT; LIVER NECROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SENESCENCE;

ADULT; AGED; BIOPSY; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SURVIVAL RATE; TISSUE DONORS;

EID: 34547619377     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000268809.86544.22     Document Type: Article

References (29)

1. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation.NEngl J Med 1996; 334: 815.
2. Pol S FH, Carnot F, et al. Predictive factorsw for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocomprised patients. Am J Gastroenterol 1998; 29: 12.
3. Sheiner PA. Retransplantation for hepatitis C: Should it be performed. Yes. Liver Transpl Surg 1997; 3 (5 Suppl 1): S18.
4. Papatheodoridis GV, Davies S, Dhillon AP, et al. The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis. Transplantation 2001; 72: 412.
5. Sheiner PA, Schwartz ME, Mor E, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21: 30.
6. Prieto M, Berenguer M, Rayon JM, et al. High incidence of allograft cirrhosis in hepatitisCvirus genotype 1b infection following transplantation: Relationship with rejection episodes. Hepatology 1999; 29: 250.
7. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823.
8. Zhou S, Terrault NA, Ferrell L, et al. Severity of liver disease in liver transplantation recipients with hepatitisCvirus infection: Relationship to genotype and level of viremia. Hepatology 1996; 24: 1041.
9. Manez R, Mateo R, Tabasco J, et al. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995; 59: 640.
10. Gretch D, Corey L, Wilson J, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: High-titer viremia correlates with advanced stage of disease. J Infect Dis 1994; 169: 1219.
11. Burak KW, Kremers WK, Batts KP, et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 2002; 8: 362.
12. Neumann UP, Berg T, Bahra M, et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 2004; 41: 830.
13. Machicao VI, Bonatti H, Krishna M, et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004; 77: 84.
14. Neuhaus P, Langrehr JM; Williams R, et al. Tacrolimus-based immunosuppression after liver transplantation: A randomised study comparing dual versus triple low-dose oral regimens. Transpl Int 1997; 10: 253.
15. Langrehr J, Nussler NC, Neumann U, et al. A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppression induction therapy following orthotopic liver transplantation. Transplantation 1997; 63: 1772.
16. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997; 25: 658.
17. Neuhaus P, Bechstein WO, Steffen R, et al. Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg 1994; 55: 426.
18. Desmet V, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513.
19. Lake JR, Shorr JS, Steffen BJ, et al. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 2005; 5: 549.
20. Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202.
21. Takada NK, Hancock WW, et al. Effects of explosive brain death cytokine activation of peripheral organ in the rat. Transplantation 1998; 65: 1533.
22. van der Hoeven JA PR, Postema F, et al. Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: a model to study marginal organ donors. Transplantation 1999; 68: 1884.
23. Pratschke J, Wilhelm MJ, Kusaka M, et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999; 67: 343.
24. van Der Hoeven JA, Ter Horst GJ, Molema G, et al. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Ann Surg 2000; 232: 804.
25. Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis:Aprospective study on the incidence and hierarchy of major complications. Gut 2004; 53: 744.
26. Hu KQ, Kyulo NL, Esrailian E, et al. Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: A retrospective study on a large cohort of patients in the United States. J Hepatol 2004; 40: 147.
27. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001; 35: 666.
28. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8 (10 Suppl 1): S14.
29. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673.